Authors: Xu, YC Johnson, KW Phebus, LA Cohen, M Nelson, DL Schenck, K Walker, CD Fritz, JE Kaldor, SW LeTourneau, ME Murff, RE Zgombick, JM Calligaro, DO Audia, JE Schaus, JM

Citation: Yc. Xu et al., N-[3-(2-dimethylaminoethyl)-2-methyl-1H-indol-5-yl]-4-fluorobenzamide: A potent, selective, and orally active 5-HT1F receptor agonist potentially useful for migraine therapy, J MED CHEM, 44(24), 2001, pp. 4031-4034